Review outlines updated classification and workup for psychodermatologic conditions
This review discusses the 2023 EADV/ESDaP/APMNA consensus classification of psychodermatologic conditions, which divides them into primary psychiatric disorders with skin manifestations versus primary dermatoses with psychiatric impact. The authors present a stepwise diagnostic framework using validated screening instruments, grounded in neuroimmune mechanisms of the mind-skin axis, and outline treatment approaches stratified by category along with thresholds for referral to psychiatry. The review states that psychiatric comorbidities affect one-third of dermatology patients but remain underrecognized.
Most relevant for: Dermatology patients with comorbid psychiatric conditions affecting or manifesting in the skin.
Read the original at Journal of the American Academy of DermatologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More dermatology updates
- Growth impairment in epidermal differentiation disorders varies by genotypeSep 30, 2026
- Expert panel issues consensus guidance on pediatric oral minoxidilSep 30, 2026
- Pustular flare risk identified after stopping biologics in psoriasisSep 25, 2026
- Class I recall: VITRUVIAS THERAPEUTICS INC: Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4Sep 23, 2026
- Delphi panel issues expert consensus on managing pseudofolliculitis barbaeSep 23, 2026